AAL Short Interest Hits Year High as Analysts Cut Targets

American Airlines reported third-quarter results on October 22 against a backdrop of mounting short positions and a steady stream of analyst target reductions, with the stock trading at $12.11 after a 3% slide over the past week.

Short interest has continued to climb since the previous notes documented the build. At 99 million shares as of October 20, equivalent to 15% of the free float, the position has grown a further 2% in a single day and is now up 20% over the past week alone. The ORTEX short score has risen in step, reaching 55.2, its highest reading in the tracked window, after spending most of the prior two weeks near 50. That trajectory matters: the score has moved from neutral territory to a level that reflects sustained bearish positioning, not a one-day spike. The lending market remains wide open for new shorts. Availability is around 404%, meaning there are roughly four shares available to borrow for every one already shorted, though that is tighter than the 695% reading from two weeks ago. Borrowing costs have actually eased further to 0.39%, down 9% on the week, so there is no financial friction discouraging bears from holding or adding.

Options traders echo the caution in the short book. The put/call ratio has been running persistently above 1.5, with the latest reading at 1.53, above its 20-day average of 1.47. That is not a dramatic z-score of 0.9, but the sustained elevated level, well above the 52-week floor of 1.35, points to an options market that has been consistently skewed toward downside protection rather than a single flush of hedging activity.

The analyst community has been uniformly moving in one direction. Every firm that has updated its price target over the past month has cut it: UBS lowered its target to $16 on October 16 while maintaining a Buy, Wells Fargo trimmed to $14, and Goldman Sachs reduced its Sell-rated target to $11. Across the group, targets have come down from the $17-$20 range to a cluster between $11 and $16. The mean sits at $15.88, implying about 31% above the current price, but that premium mostly reflects Buy and Hold ratings that were written before the recent cuts rather than fresh optimism. The EPS momentum factor scores tell the same story: 2 for the 30-day reading and 5 for 90 days, both near the bottom of the universe. What keeps the stock from being a pure consensus short is an EPS surprise score in the 95th percentile, meaning the company has consistently beaten estimates even as those estimates have been falling.

Among peers, the week's weakness has been broadly shared but AAL has not been the worst performer. DAL fell 3.7%, UAL dropped 5.3%, ALK shed 9.1%, and JBLU lost 13.1%. On that basis, AAL's 3.1% decline is closer to the steadier end of the peer group, though the one-month decline of 6.6% reflects a stock that has been under pressure for longer than a single week. PRIMECAP Management, which holds 10.5% of the company after adding 22 million shares earlier this year, and Orbis Investment Management, which built a 13.9 million share position in Q2, are the most notable institutional buyers on the register. Whether those positions have changed since mid-year is not yet known.

The next set of data to watch is what the October 22 earnings report actually showed and how the short position responded in the days that followed, given that availability remains loose enough for bears to act quickly in either direction.